Pancreatic Cancer Research

ResearcherSeoul National UniversityActive in the last 2 years

Dong Ho Lee

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8983-851X; OpenAlex author ID A5100436226. Sources: OpenAlex.

Their work

Papers
14 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
47
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: 2 papers · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 5 papers · 2024: 1 paper

Papers 14

  1. Examining neoadjuvant treatment candidates in resectable pancreatic cancer based on tumor-vessel interactions and CA 19-9 levels: a retrospective cohort study. Co-author DOI 10.1097/js9.0000000000001184↗
  2. Role of neoadjuvant treatment in resectable pancreatic cancer according to vessel invasion and increase of CA19-9 levels. Co-author DOI 10.1002/jhbp.1302↗
  3. Combination of chemotherapy and focused ultrasound for the treatment of unresectable pancreatic cancer: a proof-of-concept study. Co-author DOI 10.1007/s00330-022-09271-8↗
  4. High-resolution pancreatic computed tomography for assessing pancreatic ductal adenocarcinoma resectability: a multicenter prospective study. Co-author DOI 10.1007/s00330-023-09584-2↗
  5. Body composition analysis using convolutional neural network in predicting postoperative pancreatic fistula and survival after pancreatoduodenectomy for pancre… Co-author DOI 10.1016/j.ejrad.2023.111182↗
  6. Pancreas CT assessment for pancreatic ductal adenocarcinoma resectability: effect of tube voltage and slice thickness on image quality and diagnostic performan… Co-author DOI 10.1186/s40644-023-00637-9↗
  7. Preoperative assessment of the resectability of pancreatic ductal adenocarcinoma on CT according to the NCCN Guidelines focusing on SMA/SMV branch invasion. Last author DOI 10.1007/s00330-021-07847-4↗
  8. NO• /RUNX3/kynurenine metabolic signaling enhances disease aggressiveness in pancreatic cancer. Co-author DOI 10.1002/ijc.32733↗
  9. Preoperative CT Classification of the Resectability of Pancreatic Cancer: Interobserver Agreement. Co-author DOI 10.1148/radiol.2019190422↗
  10. Magnetic resonance with diffusion-weighted imaging improves assessment of focal liver lesions in patients with potentially resectable pancreatic cancer on CT. Co-author DOI 10.1007/s00330-017-5258-1↗
  11. Preoperative MDCT Assessment of Resectability in Borderline Resectable Pancreatic Cancer: Effect of Neoadjuvant Chemoradiation Therapy. Co-author DOI 10.2214/ajr.17.18310↗
  12. Preoperative Assessment of Pancreatic Cancer with FDG PET/MR Imaging versus FDG PET/CT Plus Contrast-enhanced Multidetector CT: A Prospective Preliminary Study. Co-author DOI 10.1148/radiol.2016152798↗
  13. Endothelial Nitric Oxide Synthase Traffic Inducer (NOSTRIN) is a Negative Regulator of Disease Aggressiveness in Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-16-0511↗
  14. DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma. Co-author DOI 10.1371/journal.pone.0031507↗

Closest collaborators

The 25 strongest of 47 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jin‐Young Jang · 8 shared papers, 2017–2024 · strength 1.20
  2. Jeong Min Lee · 5 shared papers, 2017–2023 · strength 0.58
  3. Wooil Kwon · 3 shared papers, 2021–2024 · strength 0.55
  4. Mirang Lee · 2 shared papers, 2023–2024 · strength 0.41
  5. Seung Soo Lee · 2 shared papers, 2023 · strength 0.34
  6. Ijin Joo · 4 shared papers, 2017–2019 · strength 0.32
  7. Sae‐Jin Park · 2 shared papers, 2021–2023 · strength 0.31
  8. Kyoung-Bun Lee · 3 shared papers, 2017–2021 · strength 0.28
  9. Do‐Youn Oh · 2 shared papers, 2018–2023 · strength 0.27
  10. Jeongin Yoo · 1 shared paper, 2023 · strength 0.26
  11. Su Joa Ahn · 3 shared papers, 2018–2019 · strength 0.25
  12. Eun Sun Lee · 3 shared papers, 2017–2019 · strength 0.24
  13. Hye‐Sol Jung · 1 shared paper, 2024 · strength 0.23
  14. Won‐Gun Yun · 1 shared paper, 2024 · strength 0.23
  15. Joon Koo Han · 2 shared papers, 2018–2021 · strength 0.22
  16. Jae Young Lee · 1 shared paper, 2023 · strength 0.19
  17. Kyung-Hun Lee · 1 shared paper, 2023 · strength 0.19
  18. Dong‐Hyuk Park · 1 shared paper, 2023 · strength 0.19
  19. Sang Hyub Lee · 1 shared paper, 2023 · strength 0.19
  20. Jae Seung Kang · 1 shared paper, 2023 · strength 0.18
  21. Hyeong Seok Kim · 1 shared paper, 2023 · strength 0.18
  22. Mi Hye Yu · 1 shared paper, 2023 · strength 0.18
  23. Hyun Kyung Yang · 2 shared papers, 2018–2019 · strength 0.17
  24. Nader N Hanna · 3 shared papers, 2012–2020 · strength 0.17
  25. Β. Michael Ghadimi · 3 shared papers, 2012–2020 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.